How Much Did Medlab Raise?
Funding & Key Investors

Medlab has secured $16.3M in total capital, with its most recent financing round bringing in $250K through a major strategic investment. This significant infusion of capital underscores Medlab's established presence and ongoing growth trajectory within the clinical laboratory services sector.

What is Medlab?

Medlab
Healthcare ServicesMedical Laboratories & Imaging Centers

Medlab, Inc. operates as a sophisticated clinical laboratory, focusing on specialized testing services in toxicology, molecular diagnostics, and pain management. The company provides a comprehensive PCR test for prevalent respiratory illnesses such as COVID-19, Flu, and RSV, delivering results on the same or next day, and is covered by most insurance plans. Medlab is dedicated to enhancing community health by equipping healthcare professionals, courts, and community health organizations with advanced testing technologies for accurate diagnosis and effective treatment of conditions including substance abuse and chronic pain.

How much funding has Medlab raised?

Medlab has raised a total of $16.3M across 2 funding rounds:

2008

Series D

$16M

2025

Debt

$250K

Series D (2008): $16M with participation from Primus Capital, Chrysalis Ventures, and Oxford Bioscience Partners

Debt (2025): $250K led by M&T Bank

Key Investors in Medlab

Primus Capital

Primus Capital is a U.S.-based growth-oriented private equity firm that invests in healthcare, software, and technology-enabled services companies, focusing on middle-market businesses and partnering with management teams to accelerate growth.

Chrysalis Ventures

Chrysalis Ventures is an investment firm that has invested in over 70 technology-enabled businesses across various industries, including healthcare, education, and logistics, aiming for growth through organic means and acquisitions.

Oxford Bioscience Partners

Oxford Bioscience Partners is an international venture capital firm specializing in life science technology-based investments, with offices in Boston, Massachusetts and Seoul, Korea.

What's next for Medlab?

The recent major strategic investment signifies Medlab's transition into a mature phase of enterprise-level development. This capital infusion is expected to fuel further expansion of its diagnostic capabilities, potentially through the acquisition of new technologies or strategic partnerships. Medlab is well-positioned to leverage this financial backing to solidify its market leadership and broaden its service offerings in specialized clinical diagnostics.

See full Medlab company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Healthcare Services industry

Elderly Care ServicesHealthcare Services
Healthcare ServicesMental Health & Rehabilitation Facilities
Elderly Care ServicesHealthcare Services
Healthcare ServicesVeterinary Services

Frequently Asked Questions Regarding Medlab Financial Insights

What are the most recent funding rounds that Medlab has completed, and what were the funding rounds?
Medlab has recently completed 2 funding rounds: Debt on Jun 30, 2025, Series D on Jan 14, 2008.
What is the total amount of funding Medlab has raised to date?
Medlab has raised a total of $16.3M in funding to date.
How many funding rounds has Medlab completed?
Medlab has completed 2 funding rounds.
How much funding did Medlab raise in its most recent funding round?
Medlab raised $250K in its most recent funding round.
Who are the lead investors in Medlab's latest funding round?
The lead investor in Medlab's latest funding round was M&T Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Medlab's history?
The largest funding round in Medlab's history was $16M.
See more information about Medlab